Citations

Showing 10 of 108094 citations.

Extended Anticoagulation after Radical Cystectomy Using Direct Acting Oral Anticoagulants: A Single-Institutional Experience
Durant, Adri , Mauler, David J. , Choudry, Mouneeb, Tyson, Mark D. , Mauler, David, Singh, Rohan, Faraj, Kassem , Singh, Rohan , Chang, Yu‐Hui

Mayo Clinic

Urology Practice | June 28, 2022 | Volume: 9 | Issue: 5 | Pages: 451-458

10.1097/upj.0000000000000330 | PMID 37145730 Get It

Post-operative atrial fibrillation and risk of heart failure hospitalization
Goyal, Parag , Kim, Michael , Krishnan, Udhay , McCullough, Stephen , Cheung, Jim W. , Kim, Luke K. , Pandey, Ambarish , Horn, Evelyn M. , Safford, Monika M. , Mccullough, Stephen A , Horn, Evelyn M , Cheung, Jim W , Kim, Michael , Pandey, Ambarish , Borlaug, Barry A. , Kamel, Hooman

Mayo Clinic

European Heart Journal | June 28, 2022 | Volume: 43 | Issue: 31 | Pages: 2971-2980

10.1093/eurheartj/ehac285 | PMID 35764099 Get It

Abstract Aims Post-operative atrial fibrillation (POAF) is associated with stroke and mortality. It is unknown if POAF is associated with subsequent heart failure (HF) hospitalization. This study aims to examine the association between POAF and incident HF hospitalization among patients undergoing cardiac and non-cardiac surgeries. Methods and results A retrospective cohort study was conducted using all-payer administrative claims data that included all non-federal emergency department visits and acute care hospitalizations across 11 states in the USA. The study population included adults aged at least 18 years hospitalized for surgery without a prior diagnosis of HF. Cox proportional hazards regression models were used to examine the association between POAF and incident HF hospitalization after making adjustment for socio-demographics and comorbid conditions. Among 76 536 patients who underwent cardiac surgery, 14 365 (18.8%) developed incident POAF. In an adjusted Cox model, POAF was associated with incident HF hospitalization [hazard ratio (HR) 1.33; 95% confidence interval (CI) 1.25–1.41]. In a sensitivity analysis excluding HF within 1 year of surgery, POAF remained associated with incident HF hospitalization (HR 1.15; 95% CI 1.01–1.31). Among 2 929 854 patients who underwent non-cardiac surgery, 23 763 (0.8%) developed incident POAF. In an adjusted Cox model, POAF was again associated with incident HF hospitalization (HR 2.02; 95% CI 1.94–2.10), including in a sensitivity analysis excluding HF within 1 year of surgery (HR 1.49; 95% CI 1.38–1.61). Conclusions Post-operative atrial fibrillation is associated with incident HF hospitalization among patients without prior history of HF undergoing both cardiac and non-cardiac surgeries. These findings reinforce the adverse prognostic impact of POAF and suggest that POAF may be a marker for identifying patients with subclinical HF and those at elevated risk for HF.
Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis
Parekh, Akash D. , Keller, Frank G. , McCarten, Kathleen M. , Kessel, Sandy, Cho, Steve , Pei, Qinglin , Wu, Yue , Schwartz, Cindy L. , Kelly, Kara M. , Parekh, Akash , Hodgson, David , Hoppe, Bradford S , Castellino, Sharon M. , Constine, Louis S , Hodgson, David , Hoppe, Bradford S.

Mayo Clinic

Blood | June 28, 2022 | Volume: 140 | Issue: 10 | Pages: 1086-1093

10.1182/blood.2022016098 | PMID 35763667 Get It

Abstract Children’s Oncology Group (COG) trial AHOD0431 reduced systemic therapy and used response-adapted involved-field radiotherapy (IFRT) in early-stage pediatric classic Hodgkin lymphoma. We investigated the impact of positron emission tomographic response after 1 cycle (PET1) and on IFRT outcomes and pattern of relapse. Patients in AHOD0431 underwent PET1 response assessment after AVPC (doxorubicin, vincristine, prednisone, and cyclophosphamide). “Rapid early responders” (RERs) had a negative PET1 (PET1−); “slow early responders” (SERs) had a positive PET1 (PET1+). Patients with a partial response by computed tomographic and functional imaging after 3 chemotherapy cycles received 21-Gy IFRT, whereas complete responders had no IFRT. Progression-free survival (PFS) was evaluated for RERs and SERs treated with or without IFRT. Recurrence sites were initial, new, or both. Relapses involving initial sites were characterized as “within the PET1+ site” or “initially involved but outside the PET1+ site.” Median follow-up was 118 months. The 10-year PFS rate among RERs was 96.6% with IFRT and 84.1% without IFRT (P = .10), whereas SERs were 80.9% with IFRT and 64.0% without IFRT (P = .03). Among 90 RERs who did not receive IFRT, all 14 relapses included an initial site. Among 45 SERs receiving no IFRT, 14 of 16 relapses were in the initial site (9 PET1+ site only). Among 58 patients receiving IFRT, 5 of 10 relapses were in the PET1+ site. After 3 cycles of AVPC alone, RERs showed favorable results. Conversely, SERs had unfavorable outcomes with AVPC alone, although they improved with 21-Gy IFRT. RT remains an important component of treatment for SERs. This trial was registered at www.clinicaltrials.gov as #NCT00302003.
Cardiac Implantable Electronic Devices in Ebstein Anomaly: Management and Outcomes
Tan, Nicholas Y. , Amin, Mustapha, McLeod, Christopher J. , Stephens, Elizabeth H. , Cannon, Bryan C. , Miranda, William R. , Connolly, Heidi M. , Egbe, Alexander C. , Asirvatham, Samuel J. , Madhavan, Malini , McLeod, Christopher J , Stephens, Elizabeth H , Miranda, William R , Connolly, Heidi M , Egbe, Alexander C , Asirvatham, Samuel J , Madhavan, Malini , Dearani, Joseph A.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | June 28, 2022 | Volume: 15 | Issue: 7 | Pages: No page available

10.1161/circep.121.010744 | PMID 35763435 Get It

Background: Optimal management of cardiac implantable electronic devices (CIEDs) in patients with Ebstein anomaly during tricuspid valve (TV) surgery is unknown. Thus, we aimed to characterize CIED management/outcomes in patients with Ebstein anomaly undergoing TV surgery. Methods: Patients at the Mayo Clinic from 1987 to 2020 with Ebstein anomaly and CIED procedure were reviewed for procedural details, complications, echocardiogram, and lead parameters. Five-year cumulative incidence of CIED complications were estimated using the Kaplan-Meier method. Results: Ninety-three patients were included; 51 were female, and mean age was 40.7±17.5 years. A new CIED was implanted in 45 patients at the time of TV surgery with the majority receiving an epicardial (n=37) CIED. Among 34 patients who had preexisting CIED (11 epicardial, 23 transvenous) at time of TV surgery, 20 had a transvenous right ventricular lead managed by externalizing the lead to the TV (n=15) or extracting the transvenous lead with epicardial lead implantation (n=5). Fourteen patients underwent CIED implantation (4 epicardial, 10 transvenous) without concurrent surgery. Placement of lead across the TV was avoided in 85% of patients. The 5-year cumulative incidence of CIED complications was 24% with no significant difference between epicardial and transvenous CIEDs (26% versus 23%, P =0.96). Performance of lead parameters was similar in epicardial and transvenous leads during median (interquartile range) follow-up of 44.5 (61.1) months. Conclusions: In patients with Ebstein anomaly undergoing TV surgery, the use of epicardial leads and externalization of transvenous leads to the TV can avoid lead placement across the valve leaflets. Lead performance and CIED complications was similar between epicardial and transvenous CIEDs.
Atrial Arrhythmia Ablation in Patients With D-Transposition of the Great Arteries and Atrial Switch
Chiriac, Anca , Cheema, Kamal Preet, Giardi, Davide , Espinosa, Samantha , Fitzgerald, Patrick , Perez-Downes, Julio , Umadat, Goyal , Hodge, David O. , Phillips, Sabrina D. , Madhavan, Malini , Asirvatham, Samuel J. , Cheema, Kamal P, Espinosa, Samantha M, Perez-Downes, Julio C , McLeod, Christopher J , Asirvatham, Samuel J , Giardi, Davide , McLeod, Christopher J.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | June 28, 2022 | Volume: 15 | Issue: 7 | Pages: No page available

10.1161/circep.121.010546 | PMID 35763440 Get It

Background: Patients with D-transposition of the great arteries and atrial switch have a high incidence of atrial arrhythmias. We sought to analyze the arrhythmia substrate, ablation strategies, and outcomes for catheter ablation in this population. Methods: An in-depth analysis of all clinical and procedural data in patients with D-transposition of the great arteries, atrial baffles, and atrial arrhythmia ablation was performed. Results: A cohort of 32 patients (72% male, mean age 38±7 years) underwent ablation for non-AV nodal reentrant tachycardia atrial arrhythmias, and 4 patients underwent AV nodal reentrant tachycardia ablation. Cavotricuspid isthmus flutter (CTI-flutter) was the most common arrhythmia, encountered in 75% of patients, followed by scar-related intraatrial reentrant tachycardia (non-CTI intraatrial reentrant tachycardia, 53%) and focal atrial tachycardia (focal atrial tachycardia, 6%). Among the 32 patients, 26 underwent 31 procedures at our institution. For patients with prior outside intervention, the index ablation at our institution revealed CTI-dependent flutter in 3/5 cases. However, redo ablation after an index ablation with demonstrated bidirectional CTI block revealed different/new arrhythmia substrates (80% non-CTI intraatrial reentrant tachycardia, 40% focal atrial tachycardia). Achieving bidirectional block across the CTI often required ablating on both sides of the baffle (retroaortic access, 81%; using a baffle leak, 11.5%; or transbaffle puncture, 7.7%). Combined approaches were necessary in 19% to reach the critical tissue. Acute procedural success was 81%, and recurrence was documented in 58% of patients. Despite recurrence, clinical arrhythmia burden was significantly reduced post-ablation ( P <0.001), with rare episodes, amenable to antiarrhythmic therapy. Redo ablation was required in 5 (19%) patients and uncovered new arrhythmia substrates. AV nodal reentrant tachycardia ablation also required transbaffle approaches in 3/4 patients. Conclusions: CTI-dependent flutter was the most common arrhythmia in patients with Dextro-Transposition of the Great Arteries and atrial switch. Transbaffle approaches were often necessary, and, provided that bidirectional CTI block was achieved at the index ablation, late recurrence was due to different arrhythmia mechanisms. Despite recurrence, ablation was associated with significant clinical improvement.
Rapid Geometry‐Corrected Echo‐Planar Diffusion Imaging at Ultrahigh Field: Fusing View Angle Tilting and Point‐Spread Function Mapping
Tung, Yi‐Hang , In, Myung‐Ho , Ahn, Sinyeob , Speck, Oliver , In, Myung-Ho

Mayo Clinic

Magnetic Resonance in Medicine | June 28, 2022 | Volume: 88 | Issue: 5 | Pages: 2074-2087

10.1002/mrm.29360 | PMID 35762910 Get It

PurposeSevere geometric distortions induced by tissue susceptibility, water–fat chemical shift, and eddy currents pose a substantial obstacle in single‐shot EPI, especially for high‐resolution imaging at ultrahigh field. View angle tilting (VAT)‐EPI can mitigate in‐plane distortion. However, the accompanied strong image blurring prevented its widespread applications. On the other hand, point‐spread function mapping (PSF)‐EPI can correct distortion and blurring accurately but requires prolonged scan time. We present fused VAT‐PSF‐EPI and possibilities for acceleration.MethodsMR signal equations were explicitly derived to quantify image blurring in VAT‐EPI and the maximum acceleration capacity in VAT‐PSF‐EPI. To validate the theoretical prediction, phantom measurements with varying in‐plane parallel imaging factors, slice thicknesses, and RF pulses were conducted at 7 Tesla. In addition, in vivo human brain scans were acquired with T2 and diffusion weighting to assess distortion and blurring correction.ResultsVAT can effectively suppress distortion, and the introduced image blurring is corrected through PSF encoding. Up to fourfold acceleration (only 5 shots) in VAT‐PSF‐EPI was achieved compared with standard PSF‐EPI without VAT. VAT‐induced signal loss was mitigated by adjusting the sequence parameters and EPI resolution. In vivo T2‐weighted EPI data with 1.4 mm3 resolution demonstrate immunity to water–fat chemical shift‐induced distortion. Very high‐spatial resolution diffusion‐weighted EPI (0.7 × 0.7 × 2.8 mm3 and 1.2 mm3) demonstrates the immunity to eddy current‐induced distortion.ConclusionVAT‐PSF‐EPI is a novel spin‐echo EPI‐based sequence for fast high‐resolution diffusion imaging at ultrahigh field.
SHP2 inhibition enhances Yes-associated protein–mediated liver regeneration in murine partial hepatectomy models
Watkins, Ryan , Buckarma, EeeLN H. , Tomlinson, Jennifer L. , McCabe, Chantal E. , Yonkus, Jennifer A. , Werneburg, Nathan W., Bayer, Rachel L., Starlinger, Patrick , Robertson, Keith D. , Wang, Chen , Smoot, Rory L. , Smoot, Rory L , Robertson, Keith D , Wang, Chen , Starlinger, Patrick , Yonkus, Jennifer A , Buckarma, EeeLN , Tomlinson, Jennifer , Gores, Gregory J.

Mayo Clinic

JCI Insight | June 28, 2022 | Volume: 7 | Issue: 15 | Pages: No page available

10.1172/jci.insight.159930 | PMID 35763355 Get It

Disrupted liver regeneration following hepatectomy represents an “undruggable” clinical challenge associated with poor patient outcomes. Yes-associated protein (YAP), a transcriptional coactivator that is repressed by the Hippo pathway, is instrumental in liver regeneration. We have previously described an alternative, Hippo-independent mechanism of YAP activation mediated by downregulation of protein tyrosine phosphatase nonreceptor type 11 (PTPN11, also known as SHP2) inhibition. Herein, we examined the effects of YAP activation with a selective SHP1/SHP2 inhibitor, NSC-87877, on liver regeneration in murine partial hepatectomy models. In our studies, NSC-87877 led to accelerated hepatocyte proliferation, improved liver regeneration, and decreased markers of injury following partial hepatectomy. The effects of NSC-87877 were lost in mice with hepatocyte-specific Yap/Taz deletion, and this demonstrated dependence on these molecules for the enhanced regenerative response. Furthermore, administration of NSC-87877 to murine models of nonalcoholic steatohepatitis was associated with improved survival and decreased markers of injury after hepatectomy. Evaluation of transcriptomic changes in the context of NSC-87877 administration revealed reduction in fibrotic signaling and augmentation of cell cycle signaling. Cytoprotective changes included downregulation of Nr4a1 , an apoptosis inducer. Collectively, the data suggest that SHP2 inhibition induces a pro-proliferative and cytoprotective enhancement of liver regeneration dependent on YAP.
Multiple Simultaneous Infections With Nontuberculous Mycobacteria in the Setting of GATA2 Mutation and Myelodysplastic Syndrome
Tabaja, Hussam , Rivera, Christina G. , Pruthi, Rajiv K. , Vergidis, Paschalis , Jensen, Kelsey L, Misra, Anisha , Vergidis, Paschalis , Rivera, Christina G , Tabaja, Hussam , Jensen, Kelsey

Mayo Clinic

Open Forum Infectious Diseases | June 28, 2022 | Volume: 9 | Issue: 7 | Pages: No page available

10.1093/ofid/ofac309 | PMID 35891688 Get It

Abstract GATA2 mutation can result in profoundly reduced monocytes, dendritic cells, natural killer cells, and B cells, and is associated with a predisposition for recurrent and disseminated nontuberculous mycobacterial (NTM) infections and myelodysplasias. Herein, we describe a unique case of 3 simultaneous disseminated NTM infections in a patient with GATA2 mutations.